Bank of New York Mellon Corp cut its stake in Physicians Realty Trust (NYSE:DOC – Free Report) by 2.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,681,338 shares of the real estate investment trust’s stock after selling 135,074 shares during the period. Bank of New York Mellon Corp owned 2.38% of Physicians Realty Trust worth $84,822,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Benjamin Edwards Inc. boosted its stake in shares of Physicians Realty Trust by 144.0% in the 1st quarter. Benjamin Edwards Inc. now owns 2,623 shares of the real estate investment trust’s stock valued at $39,000 after purchasing an additional 1,548 shares during the last quarter. Carderock Capital Management Inc. bought a new stake in Physicians Realty Trust during the first quarter valued at $51,000. Delta Asset Management LLC TN acquired a new stake in Physicians Realty Trust during the 4th quarter worth about $65,000. Worth Asset Management LLC bought a new position in shares of Physicians Realty Trust in the 1st quarter worth about $102,000. Finally, Wedbush Securities Inc. acquired a new position in shares of Physicians Realty Trust in the 4th quarter valued at about $147,000. Institutional investors and hedge funds own 94.67% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently commented on DOC. Wells Fargo & Company raised their target price on Physicians Realty Trust from $14.00 to $15.00 and gave the stock an “underweight” rating in a research note on Monday, August 7th. Truist Financial reiterated a “hold” rating and issued a $15.00 price objective on shares of Physicians Realty Trust in a research note on Wednesday. JMP Securities assumed coverage on shares of Physicians Realty Trust in a research note on Friday, May 26th. They set an “outperform” rating and a $15.50 target price on the stock. Morgan Stanley reaffirmed an “equal weight” rating and issued a $14.50 price target on shares of Physicians Realty Trust in a research note on Thursday, July 20th. Finally, Barclays cut their price objective on shares of Physicians Realty Trust from $18.00 to $17.00 in a research report on Friday, May 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Physicians Realty Trust currently has a consensus rating of “Hold” and a consensus price target of $16.27.
Physicians Realty Trust Stock Performance
Shares of Physicians Realty Trust stock opened at $13.73 on Friday. Physicians Realty Trust has a 52 week low of $13.27 and a 52 week high of $18.17. The company has a quick ratio of 3.51, a current ratio of 3.51 and a debt-to-equity ratio of 0.67. The business has a 50 day moving average price of $14.33 and a 200-day moving average price of $14.53. The company has a market cap of $3.27 billion, a PE ratio of 32.68, a price-to-earnings-growth ratio of 1.39 and a beta of 0.84.
Physicians Realty Trust Profile
Physicians Realty Trust is a self-managed health care real estate company organized to acquire, selectively develop, own, and manage health care properties that are leased to physicians, hospitals and health care delivery systems. The Company invests in real estate that is integral to providing high quality health care.
Read More
- Five stocks we like better than Physicians Realty Trust
- Find and Profitably Trade Stocks at 52-Week Lows
- 7 Best Bear Market ETFs to Battle a Market Decline
- What is the Shanghai Stock Exchange Composite Index?
- How to Invest in Wheat: Is it a Hedge Against Inflation?
- How to Calculate Stock Profit
- Walmart Wins the Retail Wars: Target is Losing Ground
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
